Authors
Latest:
COVID-19 Vaccines: T Cell, Antibody Responses Demonstrated in CLLPatients with chronic lymphocytic leukemia experienced functional T cell and antibody responses after receiving a vaccine for COVID-19.
Latest:
Breaking Down the Numbers for Isotretinoin AEsRecent meta-analysis takes a look at possible adverse effects of the acne medicine, their frequency and severity.
Latest:
Biosimilars Are Bringing Affordability and AccessibilityLower costs, increased availability, and assistance programs are “game changers” for patients.
Latest:
Why Is There Such A Large Disparity In Who Meets Critera For Hepatitis B Treatment?Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.
Latest:
New Drug Review: Atogepant FDA-Approved for Migraine TreatmentOn September 28, the FDA granted approval to oral atogepant (Qulipta) for the prevention of migraine.
Latest:
Q&A: Education, Accessibility Is Key for Reproductive Health Care | APhA 2025As over-the-counter birth control becomes increasingly available, pharmacists are uniquely positioned to bridge critical gaps in reproductive health care.
Latest:
The Pharmacist’s Role in Counseling Patients on GLP-1 MedicationsWith expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.
Latest:
DefenCath Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in AdultsThis new drug utilizes the bactericidal properties of taurolidine and the bloodthinning effects of heparin to maintain catheter patency.
Latest:
Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget CutsWith the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.
Latest:
OTC Considerations for COVID-19Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves
Latest:
Focus on DIR Fees: 3 Ways to Manage ThemWhen investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.
Latest:
Do’s And Don’ts: Social Media Tips for PharmacistsSocial media marketing is a powerful tool that pharmacists can use.
Latest:
Digital Health Tools in DiabetesTechnology and mobile health apps can be valuable tools in diabetes management.
Latest:
Navigating Pediatric ADHD Medication ShortagesStimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Latest:
Best Practices on Discussing Birth Control for AdolescentsThere are numerous methods of contraception available for adolescents.
Latest:
Pharmacists Discuss Their Hopes for the Future of Pharmacy in 2025 | APhA 2025Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.
Latest:
The Rise in Direct-to-Consumer Advertising of Prescription DrugsThroughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.
Latest:
Assessing and Treating Opioid Use Disorder in PregnancyOpioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.
Latest:
8 Secrets That Make Daily Facebook Posts Possible For Any PharmacyNow is the time for independent pharmacies to shine online.
Latest:
The Increasingly Relevant Role of PharmacogenomicsPharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.
Latest:
How Technology Can Reduce Pharmacy Staff BurnoutCompanies like ShiftRx are using technology to help solve the staffing shortage crisis in health care.
Latest:
FDA Approves Ceftobiprole Medocaril Sodium for 3 IndicationsThe FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.
Latest:
Health Care Hiring Trends For 2023 And BeyondHow are hiring trends shaping up for the future of health care?
Latest:
Lecanemab-irmb Approved for Alzheimer DiseaseOn January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
Latest:
New Prodrug for ADHD in School-aged ChildrenSer/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.
Latest:
Could a Cash-Based System Help Eliminate Health Care Barriers?Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.
